2026, thus far, has been characterized by one-or-two day swings back and forth. Underneath it all, the global stock market ...
Value stocks outperformed growth by a wide margin, while large-cap technology names increasingly served as sources of funds ...
ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...
ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette. 1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share. 2. The ...
ValuEngine produces 12-page PDF reports every day for around 4,100 US stocks using two distinct models—a valuation model, and a forecast model that uses the valuation model but also delivers short- ...
Equity markets finished the week with a mixed tone as leadership continued to rotate across sectors and styles. While large-cap growth and technology-oriented exposures showed modest weakness, select ...
Tech led the week, with XLK +1.87% and QQQM +0.90%, while defensives lagged (XLP –0.72%, XLU -0.16%). Over 30 days, AMD, Sandisk, and AST SpaceMobile headline U.S. gainers, while Hang Seng Bank tops ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results